MT-RNR2 and breast carcinoma: Receiver operating characteristic (ROC) curve analysis demonstrated that humanin effectively differentiated breast cancer patients from controls, with a sensitivity of 78.7% and specificity of 62.9%.<h4>Conclusion</h4>These findings suggest that humanin could serve as a promising biomarker for breast cancer screening and early detection.